Given that T cells expressing high levels of Drp1 showed enhanced inhibitory effects on lung cancer cells and tumors, we further investigated the effect of T cells with different Drp1 expression levels on the antitumor immune response of PD-1 mAbs in the treatment of lung cancer. This evidence concerns the gene PDCD1 and lung carcinoma.